13 January – 10 February (virtual)
The Oslo Medicines Initiative, a joint initiative between WHO/Europe and the Government of Norway, has launched a new series of webinars which are open to the public. The webinars will take place between 13 January and 10 February 2022.
The new webinars hope to create debate and raise awareness around the importance of improving people’s access to effective, novel medicines, which often come with a very high price tag. Equitable and sustainable access to safe, effective, affordable and quality-assured medicines is critical to achieving universal health coverage.
Despite this goal being shared by the public and private sectors, achieving it has been difficult. Patients, health systems and governments expect to have the right to reasonably priced pharmaceuticals that meet their needs, while investors and the pharmaceutical industry expect to earn sufficient profit to compensate for the risks inherent in developing or manufacturing those medicines.
Striking this balance requires collaboration between the public and private sectors. The Oslo Medicines Initiative is a neutral platform to promote this collaboration and balance.
Webinar series
To explore these issues, the webinars will gather experts and practitioners to discuss:
- current markets for innovative medicines in the WHO European Region;
- models for financing novel medicines to support innovation as a global public good;
- pricing, reimbursement and coverage policies for sustainable access to affordable innovative medicines;
- non-financial incentives for stimulating affordable innovation; and
- the role of corporate social responsibility in the context of the UN Sustainable Development Goals (SDGs).
Oslo Medicines Initiative 2022 webinar series – session summaries
Reflections on the markets for innovative medicines in the WHO European Region
Models for financing novel medicines to support innovation as a global public good
Pricing, reimbursement & coverage policies for sustainable access to affordable innovative medicines
Non-price incentives for stimulating affordable innovation
Solidarity and social contracts in the context of the UN Sustainable Development Goals (SDGs)